The region boasts a high concentration of biotech firms, university research institutions, and hospital networks involved in advanced transfusion medicine, all contributing to the acceleration of artificial blood development.
For centuries, the reliance on human-to-human blood donation has been the bedrock of transfusion medicine—a system that is both a miracle of altruism and a logistical challenge fraught with limitations.